Sofie Dhaese
- ORCID iD
-
0000-0002-2252-7167
Show
Sort by
-
- Journal Article
- A1
- open access
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients : a prospective single center observational study
-
- Journal Article
- A1
- open access
Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients
-
- Journal Article
- A1
- open access
Why we may need higher doses of beta-lactam antibiotics : introducing the 'maximum tolerable dose'
-
Pilot study of oral fluid and plasma meropenem and piperacillin concentrations in the intensive care unit
-
Augmented renal clearance in critically ill COVID-19 patients : forewarned is forearmed
-
- Journal Article
- A1
- open access
Incidence, risk factors, timing and outcome of influenza versus Covid-19 associated putative invasive aspergillosis
-
Therapeutic drug monitoring of beta-lactam antibiotics in the ICU
-
Prolonged versus intermittent infusion of β-lactam antibiotics : a systematic review and meta-regression of bacterial killing in preclinical infection models
-
- Journal Article
- A1
- open access
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure : the DIANA study
-
Corrigendum to 'Early target attainment of continuous infusionpiperacillin/tazobactam and meropenem in critically ill patients : a prospective observational study' [Journal of Critical Care 52(2019) 75–79]